Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10

References

• Bian L, Gao F, Mao Q, Sun S, Wu X, Liu S, Yang X, Liang Z. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems. Exp Rev Anti-infect Ther. 2019;17(4):233–42. doi:10.1080/14787210.2019.1585242.
   Google Scholar
• Ji T, Guo Y, Huang W, Shi Y, Xu Y, Tong W, Yao W, Tan Z, Zeng H, Ma J, et al. The emerging sub-genotype C2 of CoxsackievirusA10 associated with hand, foot and mouth disease extensively circulating in mainland of China. Sci Rep. 2018;8:13357. doi:10.1038/s41598-018-31616-x.
   PubMed Web of Science ®Google Scholar
• Munivenkatappa A, Yadav PD, Nyayanit DA, Majumdar TD, Sangal L, Jain S, Sinha DP, Shrivastava A, Mourya DT. Molecular diversity of Coxsackievirus A10 circulating in the southern and northern region of India [2009–17]. Infect Genet Evol. 2018;66:101–10. doi:10.1016/j.meegid.2018.09.004.
   PubMed Web of Science ®Google Scholar
• Yang Q, Ding J, Cao J, Huang Q, Hong C, Yang B. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of Coxsackieviruses A10. J Med Virol. 2015;87:954–60. doi:10.1002/jmv.v87.6.
   PubMed Web of Science ®Google Scholar
• Bracho MA, González-Candelas F, Valero A, Córdoba J, Salazar A. Enterovirus co-infections and onychomadesis after hand, foot, and mouth disease, Spain, 2008. Emerg Infect Dis. 2011;17:2223–31. doi:10.3201/eid1712.110395.
   PubMed Web of Science ®Google Scholar
• Okada H, Wada M, Sato H, Yamaguchi Y, Tanji H, Kurokawa K, Kawanami T, Takahashi T, Kato T. Neuromyelitis optica preceded by hyperckemia and a possible association with coxsackie virus group a10 infection. Int Med. 2013;52:2665–68. doi:10.2169/internalmedicine.52.1042.
   PubMed Web of Science ®Google Scholar
• Kumar A, Shukla D, Kumar R, Idris MZ, Jauhari P, Srivastava S, Dhole TN. Molecular identification of enteroviruses associated with aseptic meningitis in children from India. Arch Virol. 2013;158:211–15. doi:10.1007/s00705-012-1476-7.
   PubMed Web of Science ®Google Scholar
• Zhang W, Dai W, Zhang C, Zhou Y, Xiong P, Wang S, Ye X, Liu Q, Zhou D, Huang Z. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Emerging Microbes Infect. 2018;7:94. doi:10.1038/s41426-018-0094-1.
   PubMed Web of Science ®Google Scholar
• Shen C, Liu Q, Zhou Y, Ku Z, Wang L, Lan K, Ye X, Huang Z. Inactivated Coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge. Vaccine. 2016;34:5005–12. doi:10.1016/j.vaccine.2016.08.033.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang C, Liu Q, Gong S, Geng L, Huang Z. A virus-like particle vaccine protects mice against Coxsackievirus A10 lethal infection. Antiviral Res. 2018;152:124–30. doi:10.1016/j.antiviral.2018.02.016.
   PubMed Web of Science ®Google Scholar
• Jin P, Li J, Zhang X, Meng F, Zhou Y, Yao X, Gan Z, Zhu F. Validation and evaluation of serological correlates of protection for inactivated enterovirus 71 vaccine in children aged 6–35 months. Hum Vaccines Immunother. 2016;12:916–21. doi:10.1080/21645515.2015.1118595.
   PubMed Web of Science ®Google Scholar
• Gao F, Bian L, Hao X, Hu Y, Yao X, Sun S, Chen P, Yang C, Du R, Li J, et al. Seroepidemiology of Coxsackievirus B5 in infants and children in Jiangsu Province, China. Hum Vaccines Immunother. 2017;14:74–80. doi:10.1080/21645515.2017.1384107.
   PubMed Web of Science ®Google Scholar
• Sun SY, Gao F, Hu YL, Bian LL, Mao QY, Wu X, Li JX, Zhu FC, Wang JW, Liang ZL. Seroepidemiology of enterovirus d68 infection in infants and children in Jiangsu, China. J Infect. 2018;76:563–69. doi:10.1016/j.jinf.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Dai WL, Xiong P, Zhang XY, Liu Z, Chen J, Zhou Y, Ye X, Zhang C. Recombinant virus-like particle presenting a newly identified Coxsackievirus A10 neutralization epitope induces protective immunity in mice. Antiviral Res. 2019;164:139–46. doi:10.1016/j.antiviral.2019.02.016.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Manual for the virological investigation of poliomyelitis[M]. Geneva (Switzerland): World Health Organization; 2000.
   Google Scholar
• Jiang Z, Liu G, Guo-Yang L, Sun M, Xu K, Ying Z, Wang J, Li X, Li C. A simple and safe antibody neutralization assay based on polio pseudoviruses. Hum Vaccines Immunother. 2019;15:349–57. doi:10.1080/21645515.2018.1526553.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao Y, Wang C, Zheng X, Wang H, Gai W, Jin H, Yan F, Qiu B, Gao Y, et al. Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method. J Vet Sci. 2018;19:200–06. doi:10.4142/jvs.2018.19.2.200.
   PubMed Web of Science ®Google Scholar
• Du P, Brendle S, Milici J, Camacho F, Zurlo J, Christensen N, Meyers C. Comparisons of VLP-based ELISA, neutralization assays with native HPV, and neutralization assays with PSV in detecting HPV antibody responses in HIV-infected women. J AIDS Clin Res. 2015;6:433. doi:10.4172/2155-6113.1000433.
   PubMedGoogle Scholar
• Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG, et al. Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J Virol. 2010;84:1439–52. doi:10.1128/JVI.02108-09.
   PubMed Web of Science ®Google Scholar
• Wu X, Mao Q, Yao X, Chen P, Chen X, Shao J, Gao F, Yu X, Zhu F, Li R, et al. Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71. PLoS One. 2013;8:e64116. doi:10.1371/journal.pone.0064116.
   PubMed Web of Science ®Google Scholar
• Hao X, Chen P, Mao Q, Shao J, Lin H, Luo Z, Wu X, Liang Z. Establishment of a pseudovirus luciferase assay for the detection of coxsackievirus A16 neutralizing antibody. Chin J Viral Dis. 2016;6:6–11.
   Google Scholar
• Chen P, Wu X, Mao Q, Gao F, Hao X, Bian L, Zhu F, Li W, Xu M, Liang Z. A rapid and quantitative assay for measuring neutralizing antibodies of Coxsackievirus B3. J Virol Methods. 2016;232:1–7. doi:10.1016/j.jviromet.2016.02.010.
   PubMed Web of Science ®Google Scholar
• Chen P, Wu X, Su Y, Hao X, Mao Q, Liang Z. Development of a pseudovirus based assay for measuring neutralizing antibodies against Coxsackievirus B5. J Virol Methods. 2017;246:21–26. doi:10.1016/j.jviromet.2017.04.005.
   PubMed Web of Science ®Google Scholar
• Su Y, Chen P, Gao F, Bian L, Sun S, Dong F, Hu Y, Mao Q, Jiang W, Wu X, et al. A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies. Hum Vaccin Immunother. 2018;14(12):3034–40. doi:10.1080/21645515.2018.1504540.
   PubMed Web of Science ®Google Scholar
• Reed LJ, Muensch H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27:493–97.
   Google Scholar
• Braždžionytė J, Macas A. Bland–altman analysis as an alternative approach for statistical evaluation of agreement between two methods for measuring hemodynamics during acute myocardial infarction. Medicina. 2006;43:3. doi:10.3390/medicina43030025.
   Google Scholar
• Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003;9:78–85. doi:10.3201/eid1301.020112.
   PubMed Web of Science ®Google Scholar
• Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016;15:599–606. doi:10.1586/14760584.2016.1138862.
   PubMed Web of Science ®Google Scholar
• Klein M, Chong P. Is a multivalent hand, foot and mouth disease vaccine feasible? Hum Vaccines Immunother. 2015;11:2688–2674. doi:10.1080/21645515.2015.1049780.
   PubMed Web of Science ®Google Scholar
• Fu Y, Sun SY, Mao QY, Bian LL, Wu X, Zhu FC, Jiang CL, Gao F, Liang ZL. Seroepidemiology of Coxsackievirus A10 infection in infants and children: a prospective cohort study in Jiangsu, China. J Infect. 2018;77:158–64. doi:10.1016/j.jinf.2018.04.005.
   PubMed Web of Science ®Google Scholar
• Liu D, Xu L, Zhu R, Yin Z, Lin Y, Hou W, Li S, He S, Cheng T, Xia N. Development of an efficient neutralization assay for Coxsackievirus A10. Appl Microbiol Biotechnol. 2019;103:1931–38. doi:10.1007/s00253-018-09598-7.
   PubMed Web of Science ®Google Scholar